Multiple executives are putting personal capital into their own stocks. Here are the names. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

Morning Watchlist

You are receiving this email because you are subscribed to Behind the Markets. If you no longer wish to receive these emails, please unsubscribe here.

Prefer to view this content on our website? Click here.


Dear Fellow Investor,

3 Stocks Insiders Are Buying... and Why Investors Should Care

When corporate insiders buy shares of their own company, especially in open-market transactions, it’s worth paying attention. These are the people with the closest view of sales pipelines, customer churn, pricing power, cost pressures, and what’s really happening inside the business. While insider buying is not a guarantee of future returns, it can be a high-signal data point when it shows up as a cluster (multiple insiders buying around the same time) and when purchases are made with personal capital rather than through routine equity compensation.

Below are three stocks that have recently seen notable insider buying activity. For each, I’ll summarize what the company does, what insiders bought, and how to think about the opportunity and risks.


1) Rapid7, Inc. (SYM: RPD)

Recent price: about $15.89
Insider activity (cluster buying): In late November 2025, Rapid7 saw a wave of open-market purchases from multiple insiders and a large shareholder.

What insiders did (high level):

  • JANA Partners Management (a >10% owner) reported open-market purchases including 150,000 shares at ~$14.13 and 50,000 shares at ~$15.01.

  • JANA also disclosed another purchase of 41,545 shares at ~$15.71 (about $652,672).

  • CEO Corey Thomas purchased 14,500 shares at a weighted average ~$13.82 (about $200,390). 

  • Directors Thomas Schodorf (6,300 shares) and Marc Evan Brown (3,000 shares), plus director Mike Burns (2,000 shares), also bought in the open market.

Put together, these filings imply roughly $3.9 million in open-market buying across five insiders/insider entities over a short window (based on the reported transaction values above). 

What the company does: Rapid7 is a cybersecurity company focused on vulnerability management, detection/response, and security analytics—tools enterprises use to identify exposures and respond to threats.

Why the insider buys may matter:

  • Activist involvement can be catalytic. Rapid7 previously reached a settlement with activist investor JANA Partners to add directors to the board, reflecting active pressure to improve execution and shareholder value. 

  • “Many buyers, same time” is the point. A single insider buy can be noise; clustered buying suggests a broader internal view that the risk/reward is improving at current prices.

What to watch (practical checklist):

  • Evidence of stabilizing growth (billings/revenue) and improving margins.

  • Any updates around strategic alternatives and capital allocation. 

  • Continued insider behavior: do buys persist if the stock rises?

Key risks: Cybersecurity spending can be cyclical for mid-market customers; competitive intensity is high; activist situations can take longer than expected to translate into fundamentals.


Banyan Hill

The Elon Musk “Mystery Metal” That Could Break China’s Grip

mystery metal

Trump called America's rare-earth dependence a "national emergency." But one potential breakthrough… quietly engineered by Elon Musk… could end that crisis forever.

And one tiny company is sitting at the center of it all. Musk is expected to make an announcement any day now. See more about this secret project here.


2) Park Dental Partners, Inc. (SYM: PARK)

Recent price: about $13.80
Context: Park Dental Partners recently completed its IPO and began trading on Nasdaq on December 3, 2025, under ticker PARK.

Insider activity (cluster buying): A set of C-suite executives and directors disclosed purchases around the IPO period. For example:

  • CEO/Chairman Peter G. Swenson disclosed purchases including 3,846 shares at $13 (about $49,998) and an additional buy of 3,169 shares at $13 (about $41.2k).

  • Multiple additional executives/directors also reported buying at $13 (Form 4 activity summarized as a multi-insider cluster). 

Aggregating the disclosed buys in that cluster points to roughly $351K purchased across six insiders, concentrated at the IPO price level.

What the company does: Park Dental Partners operates as a dental resource organization, providing management and operational support services to affiliated dental practices (Minnesota and Wisconsin), enabling clinicians to focus on patient care.

Why the insider buys may matter:

  • Alignment post-IPO. Right after a public listing, insider purchases can signal that leadership is comfortable owning stock at the new public-market valuation, not just holding pre-IPO equity.

  • Healthcare services stability. Dental demand can be resilient over time, and scaled support services can improve practice-level economics if executed well.

What to watch:

  • Post-IPO disclosures around clinic productivity, new practice additions, and margin profile.

  • Whether the company deploys IPO proceeds into accretive expansion (organic + M&A) consistent with its stated plans. 

Key risks: Newly public companies can be volatile; integration risk is real in practice roll-ups; reimbursement and labor dynamics can pressure margins.


Trade Algo

Is this your new #1 enemy in trading?

Imagine this scenario…You are a super-intelligent investor who can scan through millions of data, detect patterns, and execute savvy trades… in just minutes. 

It would be an unfair advantage, right?

Welcome to the AI Age, where AI can make trading decisions in milliseconds.

Take Minotaur Capital as an example. 

The hedge fund replaced human analysts with AI… and… ended up beating the benchmark index by more than two times.

Here's the good news...

You can get a taste of using A.I. technology to find the top momentum trades. 

As a Behind the Markets reader, we’d like to offer you a SPECIAL gift where you can sign up for our SMS “dark pool alerts” for FREE.

Click here to claim FREE SMS dark pool alerts now.


3) QuidelOrtho Corporation (SYM: QDEL)

Recent price: about $28.84
Insider activity (cluster buying): QuidelOrtho has seen multiple open-market purchases from senior leadership and directors in late November and December.

What insiders did (examples with reported values):

  • CEO Brian Blaser bought 23,500 shares at about $21.34 (roughly $501,490). 

  • CFO Joseph Busky (via a trust) bought 4,770 shares at $26.0598 (about $124,305). 

  • Insider Mary Lake PhD Polan bought 1,000 shares (about $22,430). 

  • Director Ann Rhoads bought 750 shares (about $21,202.50). 

  • Director Joseph Jr. Wilkins bought 370 shares (about $10,341.50). 

These transactions total approximately $679K across five insiders, consistent with a meaningful “cluster buy” pattern rather than a one-off purchase.

What the company does: QuidelOrtho provides diagnostic testing solutions across lab instruments and assays, point-of-care testing, molecular diagnostics, and transfusion medicine.

Why the insider buys may matter:

  • CEO purchases tend to carry weight. A CEO materially increasing ownership is often interpreted as a high-conviction signal, particularly after volatility. 

  • Multiple functions buying. Seeing both finance leadership (CFO) and board members buying can indicate internal agreement that the stock price is discounting overly negative assumptions.

What to watch:

  • Progress on margin recovery, mix, and demand normalization across product lines.

  • Management commentary on capital allocation and operational priorities.

Key risks: Diagnostics demand can fluctuate by testing cycles and healthcare utilization; competitive and pricing pressures may persist; turnarounds can be uneven.


Stansberry

The next biggest bull run in over 50 years

Gold has shattered records, soaring past $4,000 an ounce...

But Stansberry Senior Partner Dr. David "Doc" Eifrig says history shows it could be on the verge of its biggest bull run in over half a century.

His research shows it could be triggered by a major event, eerily similar to what happened in the 1970s.

It's NOT inflation, fed rate cut expectations, escalating geopolitical tensions, or anything you're likely expecting.

And Doc believes you MUST own shares of his top gold stock.

He says you could 10x your money without touching a risky miner or a boring exchange-traded fund.

Get all the facts here.

It's the centerpiece of Doc's full gameplan for this wild market, with extraordinary upside potential.

Click here for the full details on this developing gold story.


Are there any other stocks with recent insider buys that you've got your eye on? What other sectors of the market are you currently interested in? Hit "reply" to this email and let us know your thoughts!

Our mailing address is:
Behind the Markets, LLC
4260 NW 1st Avenue, Suite 55
Boca Raton, FL 33431


Copyright © 2024 Behind the Markets, LLC, All rights reserved.
You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our Privacy Policy or our Legal Notices.

Behind the Markets

Unsubscribe

invisiblelink